Skip to content

Drug interactions

Apixaban + Elagolix

Severity: Moderate

Apixaban and Elagolix: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix inhibits P-gp and weakly to moderately induces CYP3A4, so its net effect on apixaban is uncertain. Concentrations could rise or fall, affecting bleeding or clotting risk.

What this interaction means in plain words

Apixaban and Elagolix can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apixaban belongs to Cardiovascular; Elagolix belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Opposing effects: P-gp inhibition may raise apixaban levels while CYP3A4 induction may lower them.

What to do

Monitor for both bleeding and thromboembolic events during combined use. Reassess anticoagulation if clinical changes occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apixaban and Elagolix, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apixaban with Elagolix?

MediHelp rates the interaction as moderate. Apixaban and Elagolix can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix inhibits P-gp and weakly to moderately induces CYP3A4, so its net effect on apixaban is uncertain. Concentrations could rise or fall, affecting bleeding or clotting risk.

How serious is the interaction between Apixaban and Elagolix?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for both bleeding and thromboembolic events during combined use. Reassess anticoagulation if clinical changes occur.

What other medicines interact with Apixaban?

MediHelp also lists interactions of Apixaban with, for example, Dabigatran, Defibrotide, Edoxaban. The full list is on the Apixaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in